버브제약|위스퍼

버브제약은 심혈관 질환 치료를 위한 유전자 편집 의약품을 개발합니다.

Exchange: NASDAQ

Sector: Healthcare

주가 (2025-06-30)

0.03% 전일 대비

PER

배당수익률(YoY)

0.00% than last day

실적발표예정일

미국현지시각

VERV Yearly Profit

VERV의 지난 1년동안의 수익(YoY)은 127.0% 입니다.

Do nothing but index ETF

S&P500 index ETF(VOO)의 수익과 비교해보세요.

배당액은 주식 분할 혹은 병합을 보정한 값입니다.

최근배당지급액

배당지급액(YoY) 0.00% than last year(YoY)

....

BMO Capital Kostas Biliouris	Lowers $20.0->13.5	Downgrades Outperform->Market Perform	2025-06-27 13:08:13 (EST)
HC Wainwright & Co. Mitchell Kapoor	Maintains $13.5->13.5	Downgrades Buy->Neutral	2025-06-18 07:46:22 (EST)
LifeSci Capital Cory Jubinville	Announces $->12.0	Downgrades Outperform->Market Perform	2025-06-18 07:35:06 (EST)
Jefferies Roger Song	Lowers $28.0->11.0	Downgrades Buy->Hold	2025-06-18 07:20:30 (EST)
William Blair Myles Minter	$->	Downgrades Outperform->Market Perform	2025-06-17 10:54:45 (EST)
Canaccord Genuity Whitney Ijem	Lowers $39.0->13.0	Downgrades Buy->Hold	2025-06-17 10:32:08 (EST)
William Blair Raju Prasad	$->	Reiterates Outperform->Outperform	2025-04-15 06:33:53 (EST)
Cantor Fitzgerald Rick Bienkowski	$->	Upgrades Neutral->Overweight	2025-04-15 10:06:08 (EST)